Support Intelligent, In-Depth, Trustworthy Journalism.
By Laura Santhanam
The 50-50 chance of getting either the real thing or a placebo was one of the reasons I applied -- I wanted the real deal.
By John Yang
As Russia fast tracks a coronavirus vaccine, scientists worry about skipped safety checks – and the potential fallout for trust in vaccines if something ends up going wrong.
By Abram L. Wagner, The Conversation
As the world anxiously awaits development of a vaccine for COVID-19, new and controversial research measures are being considered for the first time. These include the possibility of deliberately exposing volunteers to the disease to see if they are infected.
By Amna Nawaz, Mike Fritz, Maea Lenei Buhre
On this edition for Saturday, November 24, U.K. and Spain reach a deal on the eve of the Brexit Summit, and technology that aims to take humans out of the beginning stages of clinical trials. Later, how museums are chronicling…
By PBS NewsHour
Scientists at the Massachusetts Institute of Technology, with funding from the Department of Defense, want to speed up the clinical trial process with a device that could enable researchers to test new drugs on organ tissue grown in a lab…
By Max Blau, STAT
The time of day of your surgery could have long-term impacts on your health.
In Congress, lawmakers are close to passing a major bill that would increase funding for the FDA, the NIH and the effort to fight opioid abuse. The measure would also introduce more flexible standards for drug approvals, reducing the need…
Hospitals Dispute Failure to Disclose Clinical Study Risks for Premature Infants…
Support Provided By:
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.
Thank you. Please check your inbox to confirm.
Additional Support Provided By: